Global pharmaceutical company Eli Lilly (NYSE:LLY) reported in Q2 CY2025, with sales up 37.6% year on year to $15.56 billion. The company’s full-year revenue guidance of $61 billion at the midpoint …
Eli Lilly (NYSE:LLY) Reports Bullish Q2 But Stock Drops 14.4%
view original post